Form 4: Dynatrace Director Wolberg's RSU Vesting & New Grant
Insider Transaction Report
Dynatrace Director Kirsten O. Wolberg reported the vesting of 3,981 restricted stock units and the grant of 4,111 new units.
Summary
- Kirsten O. Wolberg, a Director of Dynatrace, Inc. (DT), filed a Form 4 to report changes in her beneficial ownership.
- On August 20, 2025, 3,981 restricted stock units (RSUs) previously granted on August 23, 2024, vested.
- These vested RSUs were part of a grant that vested 100% on the earlier of the one-year anniversary of the grant date (August 23, 2025) or the date of the Issuer's 2025 Annual Meeting of Stockholders (held on August 20, 2025).
- Following the vesting, 3,981 shares of Common Stock representing these unvested RSUs were moved from Table I (non-derivative) to Table II (derivative securities) in the filing.
- On the same date, August 20, 2025, Ms. Wolberg was granted an additional 4,111 restricted stock units.
- These newly granted RSUs will vest 100% on the earlier of the one-year anniversary of the grant date (August 20, 2026) or the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent on her continued service as a director.
- After these transactions, Ms. Wolberg beneficially owns 23,871 shares of Common Stock and 4,111 restricted stock units.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions related to director compensation (RSU vesting and new grant), which are neutral in sentiment as they are expected events and do not indicate significant positive or negative operational or financial developments.
Positives
- The grant of 4,111 new restricted stock units to Director Kirsten O. Wolberg indicates continued alignment of director incentives with shareholder interests.
- The vesting of 3,981 restricted stock units represents a successful milestone in the director's compensation plan.
Future Outlook
The newly granted 4,111 restricted stock units are scheduled to vest on the earlier of August 20, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the director's continued service.
Industry Context
The reported transactions reflect standard equity compensation practices for directors in publicly traded technology companies, aiming to align long-term interests between management and shareholders.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of director compensation is a common practice across many public companies, particularly in the technology sector, as it ties compensation directly to company performance and long-term value creation.
- The vesting schedule, typically over one year or tied to annual meetings, is also standard for director equity grants, promoting retention and sustained engagement.
Stakeholder Impact
- Shareholders: The equity grant aligns the director's financial interests with long-term shareholder value creation.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- The 4,111 newly granted restricted stock units are expected to vest on the earlier of August 20, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date 3,981 Restricted Stock Units (RSUs) were granted to Kirsten O. Wolberg. |
| 08/27/2024 | Date the 3,981 RSUs were previously reported. |
| 08/20/2025 | Earliest transaction date; Date 3,981 RSUs vested; Date 4,111 new RSUs were granted; Date of Dynatrace's 2025 Annual Meeting of Stockholders. |
| 08/21/2025 | Signature date of the Form 4 filing. |
| 08/23/2025 | One-year anniversary of the grant date for the 3,981 RSUs. |
| 08/20/2026 | One-year anniversary of the grant date for the 4,111 new RSUs. |
Keywords
Dynatrace, DT, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Stock Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.